Blog
RSS FeedPosted by Michael Wonder on 03 May 2020
Canadian prescription drug prices come under scrutiny of U.S. trade representative
1 May 2020 - The United States is keeping Canada and its plans to overhaul its drug-pricing system on a ...
Posted by Michael Wonder on 29 Apr 2020
Updated fees for CADTH Pharmaceutical Reviews
29 April 2020 - CADTH has updated the Fee Schedule for CADTH Pharmaceutical Reviews. ...
Posted by Michael Wonder on 23 Apr 2020
Vertex offers free cystic fibrosis medicines if Canada will negotiate
23 April 2020 - A maker of life saving drugs has responded to an attractiveness from the Canadian Cystic Fibrosis ...
Posted by Michael Wonder on 15 Apr 2020
Concerns grow about supply of drugs for COVID-19 patients on ventilators
14 April 2020 - People with severe cases consume some drugs at double or triple rate of other patients. ...
Posted by Michael Wonder on 08 Apr 2020
CADTH and COVID-19
8 April 2020 - If you’re looking for credible answers to your COVID-19 questions, we can help. ...
Posted by Michael Wonder on 03 Apr 2020
COVID-19 and the supply and distribution of generic and biosimilar prescription medicines in Canada
1 April 2020 - The following is a statement from Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA) ...
Posted by Michael Wonder on 02 Apr 2020
Canadian lupus patients missing critical drug after claims it treats coronavirus
1 April 2020 - It had been 90 days since Vinita Haroun last refilled her prescription of hydroxychloroquine, so it ...
Posted by Michael Wonder on 29 Mar 2020
Coronavirus a 'wake-up call' for Canada's prescription drug supply
27 March 2020 - Canadian pharmacies are limiting how much medication can be dispensed to try to prevent shortages. ...
Posted by Michael Wonder on 24 Mar 2020
Edaravone for amyotrophic lateral sclerosis: barriers to access and lifeboat ethics
23 March 2020 - Despite its unavailability in Canada, patients legally imported the drug under provisions of the Canadian Food and ...
Posted by Michael Wonder on 19 Mar 2020
Low prices won't keep new medicines out of Canada
19 March 2020 - There is no evidence of a link between pricing, research and development, and access to medicine. ...
Posted by Michael Wonder on 12 Mar 2020
CF Canada pleads with Ottawa to pave way for access to life-saving drugs
11 March 2020 - The national organisation that represents people who have cystic fibrosis is calling for changes to stop ...
Posted by Michael Wonder on 12 Mar 2020
AbbVie announces new formulary listings for Skyrizi in the treatment of moderate to severe plaque psoriasis
12 March 2020 - Non-Insured Health Benefits program lists Skyrizi on its formulary effective 21 February 2020. ...
Posted by Michael Wonder on 11 Mar 2020
Patients in the 'Fight for Our Lives' call on Parliament to STOP the PMPRB!
10 March 2020 - As the world comes together to fight coronavirus, Canadians with life-threatening rare and common diseases are ...
Posted by Michael Wonder on 08 Mar 2020
Price controls imposed by shortsighted politicians keep new life-saving drugs out
5 March 2020 - Politicians need to step outside the Ottawa bubble and understand how their policies impact the lives of ...
Posted by Michael Wonder on 05 Mar 2020
The U.S. has a problem with prescription drug prices. Canada shouldn’t try to fix it.
2 March 2020 - President Donald Trump and the U.S. Congress are scrambling to find ways to make medicines more ...